Transcriptomic analysis reveals common pathways and biomarkers associated with oxidative damage caused by

Fenghua Wei1, Tenghui Su2, Dali Wang2

  • 1State Key Laboratory of Organic Geochemistry, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, Guangzhou, 510640, China; Guangdong Key Laboratory of Environmental Pollution and Health, School of Environment, Jinan University, Guangzhou, 511443, China; University of Chinese Academy of Sciences, Beijing, 100049, China.

Chemosphere
|April 28, 2020
PubMed

Insights

This study identifies key genes and pathways affected by the mitotoxicant azoxystrobin in aquatic insects. Understanding these molecular biomarkers aids in assessing risks from mitochondrial toxicants.

Area of Science:

  • Environmental Toxicology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Chemicals can cause mitochondrial dysfunction, leading to metabolic disorders in wildlife and humans.
  • Identifying mitochondrial toxicants and understanding their mechanisms are crucial for risk assessment.

Purpose of the Study:

  • To investigate the toxic effects and mechanisms of azoxystrobin, a known mitotoxicant, in Chironomus dilutus.
  • To identify potential molecular biomarkers for assessing mitochondria-related risks.

Main Methods:

  • Exposure of Chironomus dilutus to azoxystrobin for 96 hours.
  • Analysis of lethal and sublethal outcomes.
  • Global transcriptomic profiling using RNA-sequencing.

Main Results:

  • Azoxystrobin exposure led to significant changes in key genes (ampk, acc1, atp2a, gsk3b, pi3k, fak, atr, chk1, map3k5).
  • These genes are identified as potential molecular biomarkers for azoxystrobin toxicity.
  • New toxicity pathways, including calcium ion-PI3K/AKT and cAMP-AMPK-lethality, were elucidated alongside the mitochondrial electron transfer-oxidative damage-apoptosis pathway.

Conclusions:

  • The identified genes and pathways provide insights into the toxic action of azoxystrobin and other mitotoxicants.
  • This research supports the development of adverse outcome pathways for improved risk assessment and management of mitochondrial toxicants in aquatic ecosystems.